Review of Cytotoxic CA4 Analogues that Do Not Target Microtubules: Implications for CA4 Development

Future clinical development of the CA4 pharmacophore requires that attention should be paid to abnormal CA4 analogues, which appear to retain cytotoxicity independent of canonical microtubule inhibition.